ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 4 filers reported holding ANACOR PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $34,755,000 | -49.7% | 650,231 | +6.2% | 0.01% | -50.0% |
| Q4 2015 | $69,163,000 | +10.2% | 612,230 | +14.8% | 0.03% | +3.7% |
| Q3 2015 | $62,752,000 | +90.2% | 533,107 | +25.1% | 0.03% | +107.7% |
| Q2 2015 | $32,994,000 | +171.5% | 426,113 | +102.8% | 0.01% | +160.0% |
| Q1 2015 | $12,153,000 | +343.1% | 210,079 | +147.0% | 0.01% | +400.0% |
| Q4 2014 | $2,743,000 | +184.5% | 85,045 | +116.0% | 0.00% | – |
| Q3 2014 | $964,000 | -82.4% | 39,380 | -85.6% | 0.00% | -100.0% |
| Q1 2014 | $5,488,000 | +110.7% | 274,270 | +76.7% | 0.00% | +100.0% |
| Q4 2013 | $2,605,000 | +78.2% | 155,257 | +12.8% | 0.00% | 0.0% |
| Q3 2013 | $1,462,000 | – | 137,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 5,621,423 | $59,700,000 | 36.62% |
| VHCP Management, LLC | 1,610,856 | $17,107,000 | 9.45% |
| Broadfin Capital, LLC | 1,737,669 | $18,454,000 | 3.28% |
| Consonance Capital Management LP | 737,685 | $7,834,000 | 1.96% |
| Palo Alto Investors LP | 1,600,178 | $16,994,000 | 1.78% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 520,091 | $5,523,000 | 1.06% |
| QVT Financial LP | 1,358,303 | $14,425,000 | 0.98% |
| Lombard Odier Asset Management (USA) Corp | 1,700,000 | $18,054,000 | 0.91% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,702,300 | $18,061,000 | 0.89% |
| Perceptive Advisors | 1,947,736 | $20,684,000 | 0.85% |